LymphedemaV1, PubMed, Corpus, bibRecord, 005489

Filariasis.

Identifieur interne : 005489 ( PubMed/Corpus ); précédent : 005488; suivant : 005490

Filariasis.

Auteurs : H B Routh ; K R Bhowmik

Source :

Dermatologic clinics [ 0733-8635 ] ; 1994.

RBID : pubmed:7805301

English descriptors

KwdEn :
- Antinematodal Agents (therapeutic use), Antiparasitic Agents, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (pathology), Elephantiasis, Filarial (prevention & control), Female, Filariasis (drug therapy), Filariasis (pathology), Filariasis (prevention & control), Humans, Leg (pathology), Male, Onchocerciasis (drug therapy), Onchocerciasis (pathology), Onchocerciasis (prevention & control), Skin Diseases, Parasitic (pathology), Skin Diseases, Parasitic (prevention & control), Tropical Climate.
MESH :
- chemical , therapeutic use : Antinematodal Agents.
- chemical : Antiparasitic Agents.
- drug therapy : Elephantiasis, Filarial, Filariasis, Onchocerciasis.
- pathology : Elephantiasis, Filarial, Filariasis, Leg, Onchocerciasis, Skin Diseases, Parasitic.
- prevention & control : Elephantiasis, Filarial, Filariasis, Onchocerciasis, Skin Diseases, Parasitic.
- Female, Humans, Male, Tropical Climate.

Abstract

Filariasis is found in many tropical and subtropical countries. Approximately 10% of patients with filariasis enter the end stage of the disease known as elephantiasis. The obstruction of the lymphatic system leads to massive swelling and ulceration, especially of the legs, causing deformity and difficulty in movement and function. The condition is preventable with control of the vector and early drug therapy.

PubMed: 7805301

Links to Exploration step

pubmed:7805301

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Filariasis.</title>
<author><name sortKey="Routh, H B" sort="Routh, H B" uniqKey="Routh H" first="H B" last="Routh">H B Routh</name>
<affiliation><nlm:affiliation>Department of Dermatology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bhowmik, K R" sort="Bhowmik, K R" uniqKey="Bhowmik K" first="K R" last="Bhowmik">K R Bhowmik</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:7805301</idno>
<idno type="pmid">7805301</idno>
<idno type="wicri:Area/PubMed/Corpus">005489</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005489</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Filariasis.</title>
<author><name sortKey="Routh, H B" sort="Routh, H B" uniqKey="Routh H" first="H B" last="Routh">H B Routh</name>
<affiliation><nlm:affiliation>Department of Dermatology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bhowmik, K R" sort="Bhowmik, K R" uniqKey="Bhowmik K" first="K R" last="Bhowmik">K R Bhowmik</name>
</author>
</analytic>
<series><title level="j">Dermatologic clinics</title>
<idno type="ISSN">0733-8635</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antinematodal Agents (therapeutic use)</term>
<term>Antiparasitic Agents</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (pathology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Female</term>
<term>Filariasis (drug therapy)</term>
<term>Filariasis (pathology)</term>
<term>Filariasis (prevention & control)</term>
<term>Humans</term>
<term>Leg (pathology)</term>
<term>Male</term>
<term>Onchocerciasis (drug therapy)</term>
<term>Onchocerciasis (pathology)</term>
<term>Onchocerciasis (prevention & control)</term>
<term>Skin Diseases, Parasitic (pathology)</term>
<term>Skin Diseases, Parasitic (prevention & control)</term>
<term>Tropical Climate</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antinematodal Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antiparasitic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Filariasis</term>
<term>Onchocerciasis</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Filariasis</term>
<term>Leg</term>
<term>Onchocerciasis</term>
<term>Skin Diseases, Parasitic</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Filariasis</term>
<term>Onchocerciasis</term>
<term>Skin Diseases, Parasitic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Tropical Climate</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Filariasis is found in many tropical and subtropical countries. Approximately 10% of patients with filariasis enter the end stage of the disease known as elephantiasis. The obstruction of the lymphatic system leads to massive swelling and ulceration, especially of the legs, causing deformity and difficulty in movement and function. The condition is preventable with control of the vector and early drug therapy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7805301</PMID>
<DateCreated><Year>1995</Year>
<Month>02</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted><Year>1995</Year>
<Month>02</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0733-8635</ISSN>
<JournalIssue CitedMedium="Print"><Volume>12</Volume>
<Issue>4</Issue>
<PubDate><Year>1994</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Dermatologic clinics</Title>
<ISOAbbreviation>Dermatol Clin</ISOAbbreviation>
</Journal>
<ArticleTitle>Filariasis.</ArticleTitle>
<Pagination><MedlinePgn>719-27</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Filariasis is found in many tropical and subtropical countries. Approximately 10% of patients with filariasis enter the end stage of the disease known as elephantiasis. The obstruction of the lymphatic system leads to massive swelling and ulceration, especially of the legs, causing deformity and difficulty in movement and function. The condition is preventable with control of the vector and early drug therapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Routh</LastName>
<ForeName>H B</ForeName>
<Initials>HB</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bhowmik</LastName>
<ForeName>K R</ForeName>
<Initials>KR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Dermatol Clin</MedlineTA>
<NlmUniqueID>8300886</NlmUniqueID>
<ISSNLinking>0733-8635</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000969">Antinematodal Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000977">Antiparasitic Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000969" MajorTopicYN="N">Antinematodal Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000977" MajorTopicYN="N">Antiparasitic Agents</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005368" MajorTopicYN="Y">Filariasis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009855" MajorTopicYN="N">Onchocerciasis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012876" MajorTopicYN="Y">Skin Diseases, Parasitic</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014329" MajorTopicYN="N">Tropical Climate</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>32</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>10</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">7805301</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005489 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 005489 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:7805301
   |texte=   Filariasis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:7805301" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Filariasis.

Filariasis.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki